Protein building blocks tested to fight muscle wasting in kidney patients
NCT ID NCT07437053
First seen Feb 28, 2026 · Last updated Jun 16, 2026 · Updated 14 times
Summary
This study tests whether taking branched-chain amino acids (the building blocks of protein) can safely improve muscle mass and strength in 20 adults aged 45-75 with advanced chronic kidney disease who also have muscle loss (sarcopenia). Participants will take the supplements for 6 weeks while researchers measure handgrip strength, muscle mass, and walking speed. The goal is to find a way to treat muscle wasting without overloading the kidneys with protein.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SARCOPENIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
The University of Texas Health Science Center at San Antonio
San Antonio, Texas, 78229, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.
Conditions inferred from the trial description
These were inferred from the trial's summary, not listed by the trial registrant.